ProCE Banner Activity

COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments

Podcast Episodes
In which patients with COVID-19 should we use monoclonal antibodies as prophylaxis or treatment? Hear expert insights on the timing and role of monoclonal antibody treatments for COVID-19 during the omicron era.

Released: April 21, 2022

Expiration: April 20, 2023

No longer available for credit.

Share

Faculty

Gregory Huhn

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Gregory Huhn, MD, MPHTM, has disclosed that he has received funds for research support from Lilly and consulting fees from Gilead Sciences, Janssen, and ViiV.